Zwartkruis, F. J. T. | Search bioRxiv

bioRxiv2026

HOPS is required for non-canonical mTORC1 signaling by recruiting Rags and FLCN to lysosomal membranes

The mechanistic target of Rapamycin complex 1 (mTORC1) regulates cell growth and metabolism in response to nutrient availability. mTORC1 recruitment to lysosomes by the Rag dimer complex (RagA/B and RagC/D) is a crucial step in mTORC1 signaling. Substrates of the MiT/TFE transcription factor family, like TFEB and TFE3, directly interact with the Rag complex when activated by folliculin (FLCN). This selective recruitment and subsequent phosphorylation of MiT/TFE substrates leads to a non-canonical mTORC1 signaling pathway regulating lysosomal biogenesis and autophagy. Recently, we showed that compound heterozygous mutations in VPS41 specifically impair non-canonical mTORC1 signaling. VPS41, as part of the HOPS complex, is required for fusion of lysosomes with endosomes and autophagosomes. Here we addressed the mechanism by which VPS41/HOPS complex regulates mTORC1 activity. We show that multiple HOPS subunits interact with the Rag dimers as well as with FLCN. Depletion of HOPS subunits results in reduced lysosomal localization of both Rags and FLCN, and the nuclear translocation of TFE3/TFEB. The VPS41-Rag interactions required the RING domain of VPS41, but were independent of RHEB, Rag activity or presence of other HOPS components. We conclude that HOPS is necessary for the recruitment of crucial components of the non-canonical mTORC1 signaling pathway onto lysosomal membranes. These data further our molecular understanding of disease-causing VPS41/HOPS mutations and indicate a crucial role for HOPS in connecting lysosomal trafficking to lysosomal signaling.

cell biology↗

bioRxiv2021

mTOR-activating mutations in RRAGD cause kidney tubulopathy and cardiomyopathy (KICA) syndrome

BackgroundOver the last decaces, advances in genetic techniques have resulted in the identification of rare hereditary disorders of renal magnesium and salt handling. Nevertheless, {+/-}20% of all tubulopathy patients remain without genetic diagnosis. Here, we explore a large multicentric patient cohort with a novel inherited salt-losing tubulopathy, hypomagnesemia and dilated cardiomyopathy (DCM). MethodsWhole exome and genome sequencings were performed with various subsequent functional analyses of identified RRAGD variants in vitro. ResultsIn 8 children from unrelated families with a tubulopathy characterized by hypomagnesemia, hypokalemia, salt-wasting, and nephrocalcinosis, we identified heterozygous missense variants in RRAGD that mostly occurred de novo. Six of these patients additionally suffered from DCM requiring heart transplantation in 3 of them. An additional dominant variant in RRAGD was simultaneously identified in eight members of a large family with a similar renal phenotype. RRAGD encodes GTPase RagD mediating amino acid signaling to the mechanistic target of rapamycin complex 1 (mTORC1). RagD expression along the mammalian nephron include the thick ascending limb and the distal convoluted tubule. The identified RRAGD variants were shown to induce a constitutive activation of mTOR signaling in vitro, ConclusionsOur findings establish a novel disease phenotype combining kidney tubulopathy and cardiomyopathy (KICA) caused by an activation of mTOR signaling suggesting a critical role of Rag GTPase D for renal electrolyte handling and cardiac function. SIGNIFICANCE STATEMENTHere, we report on heterozygous variants in RRAGD in patients with profound hypomagnesemia, renal salt wasting, nephrocalcinosis, and dilated cardiomyopathy. The identified RagD variants induce a constitutive activation of mTOR signaling in vitro. These findings not only establish a novel monogenic disorder of the kidney tubule, but demonstrate the essential role of mTOR signaling for distal tubular electrolyte handling and cardiac function.

genetics↗